Oxaliplatin Injection — FDA Drug Shortage

To Be Discontinued — Jiangsu Hengrui Pharmaceuticals Co., Ltd.

The FDA lists a drug shortage record for Oxaliplatin Injection (injection) from Jiangsu Hengrui Pharmaceuticals Co., Ltd. with status To Be Discontinued. The shortage was first posted on Jun 29, 2026.

Shortage details

Status
To Be Discontinued
Company
Jiangsu Hengrui Pharmaceuticals Co., Ltd.
Package NDC
25021-233-10
Dosage Form
Injection
Presentation
Oxaliplatin, Injection, 5 mg/1 mL (NDC 25021-233-10)
Initial Posting
Jun 29, 2026

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.